Market Access World USA, Boston, 23rd - 24th October 2013

Date: Sep-17-2013Featuring the top experts on market access developments across Europe, Health Network Communications will present Market Access World USA taking place at Omni Parker House, Boston this 23rd - 24th October 2013.

This two day executive conference is US focused and will facilitate discussion on the factors influencing pharmaceutical market access, including payer decision-making, reimbursement & pricing strategies and government policies. The agenda is packed full of ideas, case studies and innovative people which are ready to inspire you, your organisation and your strategy.

Dr Jacob Drapkin, VP Reimbursement & Healthcare Economics, Johnson & Johnson and will be presenting on Wednesday, 23rd October on "Why you should care about the impact of the ACA on the employer". Also on Wednesday, understand "a pharma prospective on comparative effectiveness research and how it can aid payer coverage policies" from Dr Elizabeth Engelhardt, VP Clinical Strategy& Pharmacy management, Aetna.

A host of speakers will be available to learn and network with across the two day conference including:Dr Usman Iqbal, Head of Oncology, Global Evidence & Value Development, SanofiMr Mark Lelinski, VP Americas Region Commerical, AstraZeneca
Dr Julie Locklear, VP Health Outcomes & Market Access, EMD Serono and
Cecelia Manlove, COO, Amerigroup Corporation.

Different case studies and real world examples will also be given on best practices for market access, as well as how policy changes in market access will affect your company, how HTA practice effects the markets and how innovative pricing and risk sharing models between industry and payers have changed. 

Best rates to attend the conference are available before the 4th October, and start at £1,000. For more information regarding the conference, please click here.

Event Details:

Market Access 2013

23rd-24th October 2013

Omni Parker House

Boston, MA
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.